Xie Yupei, Chen Qian, Shan Dan, Pan Xiongfei, Hu Yayi
Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, China.
Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, China.
Front Cell Infect Microbiol. 2025 Mar 7;15:1521754. doi: 10.3389/fcimb.2025.1521754. eCollection 2025.
The gut microbiota is the collective term for the microorganisms that reside in the human gut. In recent years, advances in sequencing technology and bioinformatics gradually revealed the role of gut microbiota in human health. Dramatic changes in the gut microbiota occur during pregnancy due to hormonal and dietary changes, and these changes have been associated with certain gestational diseases such as preeclampsia (PE) and gestational diabetes mellitus (GDM). Modulation of gut microbiota has also been proposed as a potential treatment for these gestational diseases. The present article aims to review current reports on the association between gut microbiota and gestational diseases, explore possible mechanisms, and discuss the potential of probiotics in gestational diseases. Uncovering the link between gut microbiota and gestational diseases could lead to a new therapeutic approach.
肠道微生物群是指存在于人体肠道内的微生物的统称。近年来,测序技术和生物信息学的进步逐渐揭示了肠道微生物群在人类健康中的作用。由于激素和饮食的变化,孕期肠道微生物群会发生显著变化,这些变化与某些妊娠疾病有关,如先兆子痫(PE)和妊娠期糖尿病(GDM)。调节肠道微生物群也被认为是治疗这些妊娠疾病的一种潜在方法。本文旨在综述目前关于肠道微生物群与妊娠疾病之间关联的报道,探讨可能的机制,并讨论益生菌在妊娠疾病中的潜力。揭示肠道微生物群与妊娠疾病之间的联系可能会带来一种新的治疗方法。